Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedApr 15, 2025
DataAggregated Company Financials
Companies61
  • 7D4.0%
  • 3M-12.2%
  • 1Y-21.7%
  • YTD-12.4%

In the last week, the Medical Equipment industry is up 1.4%, with Getinge up 4.3%. Meanwhile, Vimian Group actually underperformed within the industry, shrinking 7.4% in the last week. In contrast, the industry has lost 20% in the last 12 months. As for the next few years, earnings are expected to grow by 30% per annum.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 15 Apr 2025SEK 169.9bSEK 91.6bSEK 2.7b28.5x63.5x1.9x
Thu, 13 Mar 2025SEK 156.5bSEK 76.5bSEK 2.5b27.9x62.8x2x
Sat, 08 Feb 2025SEK 170.7bSEK 76.0bSEK 1.8b31.9x94.4x2.2x
Mon, 06 Jan 2025SEK 157.1bSEK 74.7bSEK 1.8b29.2x86x2.1x
Wed, 04 Dec 2024SEK 153.8bSEK 74.8bSEK 1.8b27.1x83.2x2.1x
Fri, 01 Nov 2024SEK 164.1bSEK 75.1bSEK 2.0b32.2x84.1x2.2x
Sun, 29 Sep 2024SEK 182.3bSEK 74.5bSEK 3.1b24.5x58.5x2.4x
Tue, 27 Aug 2024SEK 179.1bSEK 74.5bSEK 3.3b30.4x54.6x2.4x
Thu, 25 Jul 2024SEK 170.3bSEK 74.5bSEK 3.0b28.4x56.3x2.3x
Sat, 22 Jun 2024SEK 156.9bSEK 72.8bSEK 2.6b29x59.7x2.2x
Mon, 20 May 2024SEK 164.9bSEK 73.0bSEK 2.8b27.8x59.5x2.3x
Wed, 17 Apr 2024SEK 169.0bSEK 72.3bSEK 2.6b35x65.8x2.3x
Fri, 15 Mar 2024SEK 164.4bSEK 72.2bSEK 2.4b31.2x67.5x2.3x
Sun, 11 Feb 2024SEK 159.0bSEK 71.7bSEK 2.3b43.7x68.1x2.2x
Tue, 09 Jan 2024SEK 175.3bSEK 71.4bSEK 1.5b41.1x114.6x2.5x
Thu, 07 Dec 2023SEK 170.0bSEK 70.6bSEK 1.5b36.5x115x2.4x
Sat, 04 Nov 2023SEK 150.2bSEK 69.9bSEK 1.2b30.1x122.7x2.1x
Mon, 02 Oct 2023SEK 148.4bSEK 68.7bSEK 1.1b30.7x137.5x2.2x
Wed, 30 Aug 2023SEK 156.1bSEK 68.8bSEK 1.1b29.6x141.9x2.3x
Fri, 28 Jul 2023SEK 164.7bSEK 67.9bSEK 951.1m33.5x173.1x2.4x
Sun, 25 Jun 2023SEK 158.1bSEK 67.0bSEK 1.3b32.7x118.2x2.4x
Tue, 23 May 2023SEK 183.0bSEK 65.9bSEK 1.4b37.1x133.6x2.8x
Thu, 20 Apr 2023SEK 176.8bSEK 64.0bSEK 1.4b32.7x129.5x2.8x
Sat, 18 Mar 2023SEK 165.8bSEK 64.0bSEK 1.4b36.4x115.6x2.6x
Mon, 13 Feb 2023SEK 172.0bSEK 62.7bSEK 2.0b41.8x87x2.7x
Wed, 11 Jan 2023SEK 163.3bSEK 61.8bSEK 2.3b27.2x70.5x2.6x
Fri, 09 Dec 2022SEK 167.7bSEK 61.8bSEK 2.4b26.5x70.6x2.7x
Sun, 06 Nov 2022SEK 167.8bSEK 61.0bSEK 2.7b24.6x61.7x2.8x
Tue, 04 Oct 2022SEK 147.8bSEK 59.7bSEK 2.8b26.1x53.6x2.5x
Thu, 01 Sep 2022SEK 166.2bSEK 59.6bSEK 2.9b30.3x58x2.8x
Sat, 30 Jul 2022SEK 185.7bSEK 58.8bSEK 2.7b35.3x67.7x3.2x
Mon, 27 Jun 2022SEK 192.5bSEK 58.4bSEK 3.0b35.8x65.1x3.3x
Wed, 25 May 2022SEK 207.4bSEK 57.5bSEK 2.9b40.8x70.3x3.6x
Fri, 22 Apr 2022SEK 246.8bSEK 56.9bSEK 3.1b62x79.4x4.3x
Price to Earnings Ratio

79.4x


Total Market Cap: SEK 246.8bTotal Earnings: SEK 3.1bTotal Revenue: SEK 56.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 88.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 57.9x which is lower than its 3-year average PE of 88.7x.
  • The 3-year average PS ratio of 2.5x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have declined 2.8% per year over the last three years.
  • Meanwhile revenues for these companies have grown 17% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market6.78%
Healthcare4.52%
Medical Equipment4.05%
Medical Equipment6.21%
Medical Supplies0.37%
Industry PE
  • Investors are most optimistic about the Medical Supplies industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 42.3%, which is lower than the prior year's growth of 87.5% per year.
  • Investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 63.3x.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 42% over the next 5 years.
  • However this is lower than its past earnings growth rate of 88% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 26% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GETI B GetingeSEK 195.107.3%
+SEK 3.6b		-9.0%PE32.4x
XVIVO Xvivo PerfusionSEK 277.6011.7%
+SEK 913.5m		-16.4%PE50.8x
EKTA B ElektaSEK 48.285.0%
+SEK 878.8m		-38.0%PE17.8x
SUS Surgical Science SwedenSEK 126.4013.8%
+SEK 780.7m		-21.1%PE49x
IMP A SDB ImplanticaSEK 27.005.1%
+SEK 368.1m		-9.7%PS355.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

INTEG B

SEK 13.80

Integrum

7D

-6.4%

1Y

-76.8%

author-image

US Sales Focus And Axor II Will Boost Market Outlook

Apr 14 Strategic focus on U.S. market growth and marketing optimization is expected to boost revenue and improve net margins.

SEZI

SEK 3.84

Senzime

7D

-8.6%

1Y

-36.9%

EKTA B

SEK 48.28

Elekta

7D

5.0%

1Y

-38.0%

SCIB

SEK 0.40

SciBase Holding

7D

-5.4%

1Y

6.3%

BOUL

SEK 7.72

Boule Diagnostics

7D

-7.0%

1Y

-18.2%

We Think Boule Diagnostics (STO:BOUL) Has A Fair Chunk Of Debt

Apr 10
We Think Boule Diagnostics (STO:BOUL) Has A Fair Chunk Of Debt

GETI B

SEK 195.10

Getinge

7D

7.3%

1Y

-9.0%

Getinge (STO:GETI B) Is Increasing Its Dividend To SEK4.60

Apr 10
Getinge (STO:GETI B) Is Increasing Its Dividend To SEK4.60

OSSD

SEK 13.78

OssDsign

7D

25.7%

1Y

39.1%

author-image

Pure Play Orthobiologics Will Expand US Healthcare Access

Apr 07 Strategic shift to orthobiologics boosts growth and operational efficiency, enhancing future revenue and sustaining high net margins.

BACTI B

SEK 31.90

Bactiguard Holding

7D

22.2%

1Y

-54.3%

Bactiguard Holding AB (publ) (STO:BACTI B) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Apr 05
Bactiguard Holding AB (publ) (STO:BACTI B) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

SEDANA

SEK 8.28

Sedana Medical

7D

20.3%

1Y

-43.9%

author-image

US Trials And Supplier Acquisition Will Open Global Markets

Apr 04 Successful U.S. trial results and pediatric approvals across multiple countries could significantly boost revenue and market protection, expanding sales demographics.

ARCOMA

SEK 8.64

Arcoma

7D

-3.8%

1Y

-25.8%

XVIVO

SEK 277.60

Xvivo Perfusion

7D

11.7%

1Y

-16.4%

Xvivo Perfusion AB (publ)'s (STO:XVIVO) Intrinsic Value Is Potentially 36% Above Its Share Price

Apr 03
Xvivo Perfusion AB (publ)'s (STO:XVIVO) Intrinsic Value Is Potentially 36% Above Its Share Price

VIMIAN

SEK 37.90

Vimian Group

7D

-4.3%

1Y

17.7%

IMP A SDB

SEK 27.00

Implantica

7D

5.1%

1Y

-9.7%

SUS

SEK 126.40

Surgical Science Sweden

7D

13.8%

1Y

-21.1%

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%

Mar 14
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%

LUMITO

SEK 0.42

Lumito

7D

-1.7%

1Y

-70.3%

Health Check: How Prudently Does Lumito (NGM:LUMITO) Use Debt?

Jan 08
Health Check: How Prudently Does Lumito (NGM:LUMITO) Use Debt?